APA (7th ed.) Citation

PMG, S., NJ, M., K, L., S, L., D, Y., JE, B., & EF, G. (2022). Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017. JAMA health forum, 3(1), e214468. https://doi.org/10.1001/jamahealthforum.2021.4468

Chicago Style (17th ed.) Citation

PMG, Santos, Mathis NJ, Lapen K, Lobaugh S, Yerramilli D, Bekelman JE, and Gillespie EF. "Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017." JAMA Health Forum 3, no. 1 (2022): e214468. https://doi.org/10.1001/jamahealthforum.2021.4468.

MLA (9th ed.) Citation

PMG, Santos, et al. "Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017." JAMA Health Forum, vol. 3, no. 1, 2022, p. e214468, https://doi.org/10.1001/jamahealthforum.2021.4468.